Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Trial of Everolimus- and Zotarolimus-eluting Stents for Treatment of Unprotected Left Main Coronary Artery Disease: ISAR-LEFT-MAIN-2

NCT00598637 is registered in ClinicalTrials.gov with Deutsches Herzzentrum Muenchen as lead sponsor.

NCT NCT00598637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00598637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Trial of Everolimus- and Zotarolimus-eluting Stents for Treatment of Unprotected Left Main Coronary Artery Disease: ISAR-LEFT-MAIN-2
Lead sponsor
Deutsches Herzzentrum Muenchen
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2007
Completion date
February 28, 2013
Enrollment
650 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

coronary disease